Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
11/2010
11/24/2010CN101137641B Benzothiophen-2-carbonylguanidine derivatives, preparation thereof, and pharmaceutical composition containing the same
11/23/2010US7838550 5-chloro-[N-3,3,3-trifluoro-1-(hydroxymethyl)-2-(trifluoromethyl)propyl]thiophene-2-sulfonamide by reacting 2-amino-4,4,4-trifluoro-3-(trifluoromethyl)butan-1-ol and 5-chlorothiophene-2-sulfonyl chloride 4-methylmorpholine base; isopropyl acetate solvent; one step; beta amyloid inhibitor for Alzheimer's
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7838520 Inhibitors of histone deacetylase
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292229 Tryphostin-analogs for the treatment of cell proliferative diseases
11/17/2010EP2251335A1 Branched compounds, organic thin films made by using the same, and organic thin film devices
11/17/2010EP2251326A1 Heterocyclic compound
11/17/2010EP2250160A1 Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
11/17/2010EP2250150A1 Leukotriene b4 inhibitors
11/17/2010EP2249828A1 Preparation of sulfamide derivatives
11/17/2010CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound
11/17/2010CN101888997A Synthesis of quaternary salt compounds
11/17/2010CN101885720A Method for synthesizing 2-thiophene ethylamine
11/16/2010US7834062 Aminoalkylphenols, methods of using and making the same
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834013 Racemic-(trans)-2-[4-({[3-(phenyloxy)phenyl]methyl}ammonium)phenyl]cyclopropanecarboxylic acid; type II diabetes; G protein-coupled receptor 40 (GPR40) agonists
11/16/2010US7834004 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/11/2010WO2010128163A2 Small molecule inhibitors of influenza a and b virus and respiratory syncytial virus replication
11/11/2010WO2010127928A1 Insecticidal compounds
11/11/2010WO2010127439A1 Ammo acid derivatives for the treatment of neuropathic pain
11/11/2010US20100286412 Synthesis and preparations of duloxetine salts
11/11/2010US20100286215 Bis-aromatic compounds useful in the treatment of inflammation
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010US20100286092 Beta-lactamase inhibitors
11/11/2010CA2799157A1 Ammo acid derivatives for the treatment of neuropathic pain
11/11/2010CA2759592A1 Insecticidal compounds
11/10/2010EP2248818A1 Organic semiconductor material
11/10/2010EP2248809A1 Alkyl-3-[2-(benzo[b]thiophen-5-yl)-ethoxy]-propanoates as intermediates in the production of Azetidin-3-ol derivatives
11/10/2010EP2247583A1 Hydrazines in glaucoma therapy
11/10/2010EP2247196A2 Sweetener compositions and methods of making them
11/10/2010CN101883760A Heteroaryl amides useful as inhibitors of voltage-gated sodium channels
11/10/2010CN101880272A (-)-4,4'-dimethyl-2,2'-[thiophene-2,5-dimethylacylamino] diamyl acid methyl ester, (-)-4,4'-dimethyl-2,2'-[thiophene-2,5-dimethylacylamino] diamyl acid and preparation method thereof
11/10/2010CN101880271A Synthesis method of 2-thiophene acetylchloride
11/10/2010CN101033232B Method of preparing olanzapine crystal system I
11/09/2010US7829731 used as an intermediate in synthesis of Duloxetine antidepressant drug
11/09/2010US7829639 Composition for conductive layers in electronic devices
11/09/2010US7829597 preventing the formation of insoluble A beta and arresting the production of A beta; beta-site amyloid precursor protein-cleaving enzyme; 3-[(2-amino-2-methyl-3-phenylpropoxy)methyl]-N-[(1R)-1-(4-fluorophenyl)ethyl]-[methyl(methylsulfonyl)amino]benzamide
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
11/09/2010US7829501 Fungicidal composition containing acid amide derivative
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2009137081A3 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/04/2010WO2008148747A8 Pdz domain modulators
11/04/2010US20100280250 Therapeutic and delivery methods of prostaglandin ep4 agonists
11/04/2010US20100280093 Process for the preparation enantiomerically pure salts of n-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine
11/04/2010US20100280081 Anti-inflammatory agents as virostatic compounds
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280075 Paclitaxel enhancer compounds
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280036 Modulation of Pathogenicity
11/04/2010US20100280034 Modulation of pathogenicity
11/04/2010US20100280026 Compositions useful as inhibitors of protein kinases
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279983 Novel inhibitors of beta-lactamase
11/04/2010US20100279868 Novel herbicides
11/04/2010US20100278733 Composition for diagnosis of amyloid-related disease
11/04/2010US20100277063 Fluorene-based derivative and organic electroluminescence device employing the same
11/04/2010CA2760387A1 Thiophene derivative
11/03/2010EP2246343A1 Process for production of thiophene compound and intermediate thereof
11/03/2010EP2244998A2 Elansolids, novel natural metabolites of flexibacter and antibiotically active derivatives thereof
11/03/2010EP1745002B1 Novel compounds, their preparation and use
11/03/2010CN101878207A Conjugated compound, nitrogenated condensed-ring compound, nitrogenated condensed-ring polymer, organic thin film, and organic thin film element
11/03/2010CN101875654A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
11/03/2010CN101875651A Production method of 3-methyl sulfolane
11/03/2010CN101875590A Method for synthesizing acrylamide compound
11/02/2010US7825154 nonpeptidic inhibitors of Botulinum neurotoxin A metalloprotease activity, such as 2-[4-(4-carbamimidoylphenoxy)phenyl]-1H-indole-5-carboximidamide, used for treating, inhibiting or preventing intoxication caused by bacteria
11/02/2010CA2470391C N,n'-disubstituted piperazine compounds and their use as analgesics
11/02/2010CA2400167C Insecticidal anthranilamides
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122810A1 Aromatic amine derivative, and organic electroluminescent element comprising same
10/28/2010WO2010122294A1 Thiophene inhibitors of ikk-b serine-threonine protein kinase
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100273883 Novel ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
10/28/2010US20100273835 Novel compounds
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273763 Organometallic complexes as therapeutic agents
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010CN1984897B Light-emitting device material and light-emitting device
10/27/2010CN1668303B Selective estrogen receptor modulators containing a phenylsulfonyl group
10/27/2010CN1602290B Process for the synthesis of chirally pure beta -amino-alcohols
10/27/2010CN1585633B Phenethanolamine derivatives for treatment of respiratory diseases
10/27/2010CN101874018A N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
10/26/2010US7820846 by phosgenation of an aminobenzoylsulfamic acid amide intermediate; prepared from a p-nitrobenzoyl chloride or benzoate and a sulfamic acid amide and reducing the nitrobenzoylsulfamic acid amide; isocyanates are crop protection agents
10/26/2010US7820837 Condensed ring compound
10/26/2010US7820717 4-Chloro-2-phenylsulfanyl-phenyl)-4-isopropoxy-benzenesulfonamide; inflammatory bowl disease such as Crohn's disease or Colitis
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/26/2010CA2412164C Amidine derivatives as selective antagonists of nmda receptors
10/21/2010WO2010120400A2 Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors
10/21/2010WO2010120099A2 Process for preparation of dialkoxythiophenes and alkylenedioxythiophenes
10/21/2010WO2010119902A1 Process for production of 2-alkyl-3-aminothiophene derivative
10/21/2010WO2010086878A3 Thyroid receptor modulators
10/21/2010WO2009122445A3 Donor- acceptor fluorene scaffolds : a process and uses thereof
10/21/2010US20100267968 Method for the preparation of duloxetine hydrochloride
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 329